October 2025 in “The American Journal of Gastroenterology” This report describes a case of SAPHO syndrome likely triggered by escalated dosing of infliximab in a 21-year-old woman, highlighting the complex nature of infliximab-induced adverse events, and suggesting a potential autoimmune basis involving two distinct pathophysiologies for SAPHO syndrome.
Results are not directly reported in the abstract; instead, it mentions studies related to treatments and observations in dermatological conditions like atopic dermatitis, psoriasis, alopecia areata, and other skin disorders, focusing on various interventions and potential advancements in these areas.
May 2025 in “The Journal of Rheumatology” In this case report, two patients with coexisting systemic lupus erythematous and neuromyelitis optica spectrum disorder achieved remission of SLE activity using an anti-CD19 monoclonal antibody.